Important Notice: Our web hosting provider recently started charging us for additional visits, which was unexpected. In response, we're seeking donations. Depending on the situation, we may explore different monetization options for our Community and Expert Contributors. It's crucial to provide more returns for their expertise and offer more Expert Validated Answers or AI Validated Answers. Learn more about our hosting issue here.

Are there any warnings regarding the use of AmBisome?

April 26, 2017ambisome warnings

0

Posted

Are there any warnings regarding the use of AmBisome?

1 Answer

0

Posted

Anaphylaxis has been reported with amphotericin B deoxycholate and other amphotericin B-containing drugs, including AmBisome. If a severe anaphylactic reaction occurs, the infusion should be immediately discontinued and the patient should not receive further infusions of AmBisome. Return to Top AmBisome® is a registered trademark of Gilead Sciences, Inc. Abelcet® is a registered trademark of Enzon Pharmaceuticals, Inc.